Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Enanta Pharmaceuticals (ENTA) over the last 6 years, with Sep 2025 value amounting to $21,336.

  • Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) rose 0.85% to $21,336 in Q3 2025 from the same period last year, while for Sep 2025 it was $21,336, marking a year-over-year increase of 0.85%. This contributed to the annual value of $21,336 for FY2025, which is 0.85% up from last year.
  • Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) amounted to $21,336 in FY2025, which was up 0.85% from $21,157 recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $21,336 in FY2025 and a low of $20,171 during FY2021.
  • In the last 3 years, Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $21,157 in 2024 and averaged $21,154.
  • Data for Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY increased of 2.14% (in 2022) over the last 5 years.
  • Over the past 5 years, Enanta Pharmaceuticals' Shares Outstanding (Diluted Average) (Yearly) stood at $20,171 in 2021, then increased by 2.14% to $20,603 in 2022, then climbed by 1.78% to $20,969 in 2023, then increased by 0.90% to $21,157 in 2024, then increased by 0.85% to $21,336 in 2025.